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ASSESMENT  OF  LEFT MAIN CORONARY  STENOSIS  BY  
TRANSESOPHAGEAL  ECHOCARDIOGRAPHY 
   INTRODUCTION 
Quantitative evaluation of coronary stenosis is clinically important. Quantitative coronary 
angiography is usually performed for estimating the severity of coronary stenosis. 
Intracoronary blood flow velocity measurements using Doppler catheters or Doppler 
ultrasound guide systems have also been proposed as an alternative method for evaluating the 
functional severity of coronary stenosis at baseline as well as for assessing the results of 
interventional procedures . Johnson et al. demonstrated, in a canine model, that the cross-
sectional area (CSA) of the coronary stenosis can be calculated with a Doppler catheter using 
the continuity equation, which was originally introduced for measuring stenotic valve area 
More recently, Nakatani et al. showed, in 13 patients with mild to moderate stenosis, that 
application of the continuity equation to Doppler catheter measurement of coronary flow 
velocity can be used to successfully compute the severity of coronary stenosis. These 
methods, however, remain invasive, requiring cardiac catheterization, and cannot be repeated 
without risk during serial follow-up studies. Furthermore, in a consecutive series of 52 
patients undergoing percutaneous transluminal coronary angioplasty, Di Mario et al. found 
that, although the percent CSA stenosis derived from the intracoronary guide wire Doppler 
measurements based on the continuity equation were significantly correlated with the 
corresponding quantitative angiographic measurements, this determination could be achieved 
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in only 16% of cases. Recently, it has been demonstrated that coronary blood flow velocity 
can be recorded in the proximal part of the left coronary artery (LCA) with the use of 
transesophageal Doppler echocardiography (TEDE). In the present study, we tested whether 
the percent reduction of CSA of the stenosis can be quantitated by TEDE using the continuity 
equation. 
REVIEW OF LITERATURE: 
Discussion  
The epicardial coronary artery system consists of the left and right coronary arteries, which 
normally arise from ostia located in the left and right sinuses of Valsalva, respectively  In 
about 50% of humans a "third coronary artery" ("conus artery") arises from a separate ostium 
in the right sinus. The left main (LM) coronary artery ranges in length from 1 to 25 mm 
before bifurcating into the left anterior descending (LAD) and left circumflex (LC) branches. 
The LAD coronary artery measures from 10 to 13 cm in length, whereas the usual 
nondominant LC artery measures about 6 to 8 cm in length. The dominant right coronary 
artery (RCA) is about 12 to 14 cm in length, before giving rise to the posterior descending 
artery(PDA) The subepicardial coronary arteries run on the surface of the heart embedded in 
various amounts of subepicardial fat. Portions of the epicardial coronary arteries may dip into 
the myocardium ("mural artery " or "tunneled artery") and be covered for a variable length (1 
to several mm) by ventricular muscle ("myocardial bridge"). However, the coronary artery 
size was greater in the male patients as compared to females in the left coronary system. 
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Interestingly, the diameter of the right coronary artery and its branches were comparable in 
both males and females. 
 
                      Coronary artery size in Indians has been reported to be significantly smaller when 
compared to that of the  western population8,15,16 . This has been attributed to body habitus, 
build & the body surface area. Lip8 reported that though the unadjusted angiographically 
estimated mean diameters of various coronary artery segments in the western population 
among Caucasians were higher than those of Indian Asians there was no statistically 
significant difference when these were indexed to the body surface area leading them to the 
conclude that the smaller size of the coronaries in Indian Asians is attributable to their 
relatively smaller body surface area. In terms of graftable arteries during CABG, Indian 
patients may have an LAD which is smaller, no significantly smaller obtuse marginal 
branches but indeed a larger RCA and branches. Similar findings have been reported by 
Dhawan4, 15.The smaller dimension of some coronary arterysegments has important 
diagnostic and therapeutic implications since for any interventional procedure the absolute 
size of the coronary arteries matters12. It has been reported that occlusion or thrombosis is 
more common in vessels less than 2.5 mm in diameter8. A moderate (60%) stenosis in a 2.5 
mm vessel would have more effects on flow than the same degree of stenosis in a 3.5 mm 
vessel as the cross sectional area in the former would be reduced to 1.76 mm2 as compared to 
3.46 mm2 in the larger vessel. Thus a moderate plaque would cause significant obstruction in 
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a small vessel with significant implications in coronary revascularization. Among patients 
with stable angina, certain findings on exercise testing, such as early or pronounced ischemic 
ECG changes in stage I or II of the Bruce protocol or at heart rates less than 120 beats/min or 
a high risk Duke treadmill score, can identify patients who are more likely to have left main 
coronary artery disease 
 Significant, defined as a greater than 50 percent narrowing, left main coronary artery 
disease, is found in 4 to 6 percent of all patients who undergo coronary arteriography [1]. 
When present, it is associated with multivessel coronary artery disease (MVCAD) over 70 
percent of the time [2]. Most patients are symptomatic and at high risk of cardiovascular 
events, since occlusion of this vessel compromises flow to at least 75 percent of the left 
ventricle, unless they are protected by collateral flow or a patent bypass graft to either the left 
anterior descending or circumflex artery. Studies performed before revascularization with 
CABG became the standard of care revealed a poor prognosis for these patients, with three-
year survival as low as 37 percent [3]. stenosis of the left main coronary artery (LMCA) is 
found in 3%–5% of patients undergoing coronary angiography.1 Total occlusion of the 
LMCA, defined as the complete absence of antegrade flow of contrast beyond the bifurcation 
of the LMCA, is rare. The rarity of this condition in an angiographic series may be due to the 
high mortality in this subgroup. Traditionally, coronary artery bypass graft surgery has been 
considered the treatment of choice for these patients. However, percutaneous 
revascularization is being increasingly performed in such patients. 
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Causes of left main coronary artery disease 
a) Atherosclerosis 
b) Non atherosclerotic causes: 
c) Irradiation 
d) Takayasus arteritis 
e) Syphilitic aortitis 
f) Rheumatoid arthritis 
g) Aortic valve disease 
h) Kawasaki disease 
i) Injury after left main coronary intervention or cardiac surgery 
j) Idiopathic causes 
 
 
  
 
6 
 
 
2. Normal flow was laminar with a distinctly phasic character (diastolic predominance). 
Mean values of peak coronary flow velocity (in cm/sec) for systole and diastole were: 
 
Artery                                 Sys                                                 Dia 
LMCA                                 36                                                   71 
LAD                                   31                                                    67 
 
LCX                                   36                                                    75 
 
RCA                                  25                                                    29 
Coronary artery bypass graft surgery (CABG) has usually been recommended for left main 
disease in symptomatic patients. As will be described below, CABG is associated with a 
significant improvement in important cardiovascular outcomes compared to medical therapy, 
including mortality [4]. Percutaneous coronary intervention (PCI) has usually been restricted 
to patients considered inoperable, at high risk for CABG, or with prior CABG and at least 
one patent graft to the left anterior descending or circumflex artery (so-called "protected" left 
main disease). Graft patency is important in this setting in the event of acute or late closure 
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after PCI. The prevalence of significant (> 50%) isolated LMCA stenosis varies from 0.25 to 
1.3 percent in patients undergoing diagnostic catheterization (24). In about 80 percent of 
patients with LMCA stenosis there is concomitant significant atherosclerosis in other major 
coronary vessels. The reported prevalence of LMCA stenosis varies from 2.5 to 10 percent 
depending upon the cohort of patients studied in different series (25,26). The prevalence of 
significant LMCA stenosis has been reported to be approximately nine percent in patients 
undergoing bypass surgery, approximately five percent in patients with chronic angina and 
about seven percent in patients with AMI (27,28). 
Protected Versus Unprotected LMCA Stenosis 
Left main trunk (LMT) or LMCA is defined as “Protected” when there is atleast one patent 
bypass graft to the left circumflex (LCX) or left anterior descending (LAD) artery. In the 
absence of such a patent graft, LMCA (LMT) is said to be unprotected. The intervention for 
protected or unprotected LMD may be elective or in emergency. Unfortunately, in the 
literature there is lot of mix-up about the results of these groups (29). The distinction becomes 
important when outcome from different studies are to be compared. The interventions 
performed in emergency usually are in critically ill patients presenting with haemodynamic 
collapse. In contrast, the elective interventions are performed in relatively stable patients. 
During the last few years, the number of elective interventions in unprotected LMD have 
increased. Initially, LMCA elective interventions were performed only in CABG ineligible 
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patients or in those with limited life expectancy. In the post stent era, the indications of 
elective LMCA interventions have widened and even includes CABG eligible patients with 
normal or reduced left ventricular (LV) function. 
Percutaneous reperfusion of LMCA stenosis complicated by AMI 
There is a paucity of data on outcomes of patients undergoing emergency percutaneous or 
surgical revascularisation of LMD complicated by AMI. Initial studies on percutaneous 
revascularisation in patients with AMI and LMD reported very poor in-hospital results. In a 
series of 6 patients reported by Chauhan et al (31), the in-hospital mortality was 83% (5/6 
patients) and led the authors to conclude that there is a prohibitive risk for percutaneous 
revascularisation in LMD complicated by AMI. Quigley et al. (32) reported the in-hospital 
outcome of 34 patients with AMI and LMD. Out of these, 16 patients were in cardiogenic 
shock; 7 patients were treated medically, 4 were managed with PTCA, and 5 with CABGS. 
The overall mortality rate was 100% (4/4 patients) in the PTCA group and 100% (7/7 
patients) in the medical treatment group; the surgical revascularisation group mortality rate 
was 89% (8/9 patients). 
In contrast to poor results in earlier studies, the outcomes in ULTIMA registry (33) and in 
study by Neri et al (34) are more favourable. The better results in these series can be attributed 
to use of intracoronary stents, newer antiplatelet therapy and mechanical support. In 
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ULTIMA (Unprotected left main trunk intervention multicenter assessment) multicentric 
registry from 13 countries (33), 40 patients underwent percutaneous LMCA interventions for 
AMI with in hospital mortality of 55% and 18% requiring CABGS. Neri et al (34) reported 
results of PCI in 22 patients with most (82%) of the patients presenting in cardiogenic shock. 
The primary success of PCI was 91% and primary stenting was performed in 17 patient 
(77%). The overall in-hospital mortality was 50% (11/22 patients) and all deaths were due to 
refractory shock. The 6-month survival rate was 41% 1%, while the event-free survival was 
27% 10%. At 6-month follow up, the mortality rate increased to 59%, the target vessel 
revascularisation rate was 14%. The results of ULTIMA registry and data of Neri et al (33,34) 
suggest that emergency percutaneous revascularisation in patients with LMD and AMI is 
technically feasible. The benefit of percutaneous coronary interventions on mortality is 
likely. However, the small number of patients prevents any definitive conclusion. 
With respect to the emergent CABGS for LMD complicated by AMI, the only reported data 
are those of Nakanishi et al. (35) and are based on a series of 13 patients. The mortality rate 
was 46% for the entire group and 53% for the patients presenting with cardiogenic shock. 
These results are comparable to those observed by Neri et al (34) and by ULTIMA registry 
experience (33). However, the paucity of data does not allow any conclusion on whether 
percutaneous or surgical reperfusion is preferred in patients with LMD complicated by AMI. 
Adjunctive intra-aortic balloon pump (IABP) is mandatory when PCI of LMD is performed 
during emergency, during AMI, in cardiogenic shock and in haemodynamically unstable 
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patients. Emergency LMCA intervention has also been performed using retrograde perfusion 
via the coronary sinus and retroinfusion of coronary veins by using extra corporal membrane 
oxygenation pump.  
Long Term Clinical Outcomes 
Park SJ et al (39) in a recent study reported long term outcome of 127 consecutive cases who 
underwent elective stenting of unprotected LMCA. At two years the cumulative survival rate 
was 97.0 1.7% and the cardiac event-free survival rate was 86.9 3.3%. Similar figures have 
been reported by Silvestri and colleagues (17) in a low risk population. One-year mortality 
reported by Park and colleagues was 5.7% and the same figures have been reported in low-
risk group CABGS series (40). The mortality rate in this series over two-year followup was 
3.1%, which is acceptable. 
For patients with restenosis, CABG was recommended first. However, other modalities of 
treatment included repeat angioplasty using RA with or without radiation therapy. In this 
series of Park et al (39) after six months, there were no cardiac deaths or target lesion 
revascularizations, indicating that the long-term clinical course may be excellent after 
unprotected LMCA stenting in selected patients with normal left ventricular function. This 
result is consistent with previously published data showing that the restenotic process after 
stenting is time-limited and that little progression occurs beyond six months. 
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Tan WA et al. (37) on behalf of ULTIMA investigators reported long term clinical outcome 
after PCI of unprotected LMCA in 279 patients. Thirty (13.7%) patients died in hospital, and 
the rest were followed up for a period of 19 months. The 1-year incidence was 24.2% for all-
cause mortality, 20.2% for cardiac mortality, 9.8% for myocardial infarction, and 9.4% for 
CABGS. Independent correlates of all-cause mortality were LVEF 30%, mitral regurgitation 
grade 3 or 4, presentation with myocardial infarction and shock, creatinine 2.0 mg/DL, and 
severe lesion calcification. For the 32% of patients (low risk group) < 65 years old with left 
ventricular ejection fraction > 30% and without shock, the prevalence of these adverse risk 
factors was low. No periprocedural deaths were observed in this low-risk subset, and the 1-
year mortality was only 3.4%. On the basis of this data it becomes obvious that patients 
undergoing unprotected LMCA PCI are the ones with serious comorbidities and 
consequently have high event rates. PCI may be an alternative to CABG for a select 
proportion of elective patients (low risk group) and may also be appropriate for highly 
symptomatic inoperable patients.  
Finally, on the basis of the 2% per month death rate among hospital survivors noted over the 
first 6 months after hospital discharge, probably partly a result of restenosis, it is strongly 
recommended to have surveillance coronary angiography at 2 and 4 months post PCI.  
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Role Of CABGS In LMCA Stenosis 
CABGS has been standard of care for LMD ever since the veterans administrations 
cooperative study established its superiority over medical treatment with regards to survival 
(41). PCI was shown in randomized clinical trials in the 1990's to be equivalent to CABGS in 
terms of rates of survival and infarct free-survival in a growing number of patients with 
coronary artery disease. It is highly unlikely that there will be randomized clinical trials to 
compare results of PCI and CABGS in LMCA stenosis because of logistic considerations of 
prohibitive sample size and cost requirements. 
From the available data, based on clinical studies and registries there is no doubt that PCI is 
an alternative to CABGS in selected cases. Judicious patient selection remains critical for 
both the interventionalist and cardiac surgeon, and further studies are needed to define which 
patients are truly inoperable, who among these patients still may benefit from PCI, and those 
in whom revascularisation attempts will be futile. Unfortunately, patients who are good 
candidates for surgery are typically the same ones who will do well with other invasive 
procedures, and poor surgical risks often mean poor global risks. It is fair to say that CABGS 
is still the first choice for the majority of patients with LMD, but PCI is a viable option in 
select circumstances : those presenting with AMI, the highly symptomatic but inoperable 
patient, and perhaps the low-risk patient group discussed above. 
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This concern about closure has been minimized by stent implantation, which has led to 
increasing evaluation of PCI for left main disease. Interest in elective left main stenting has 
further intensified with the availability of drug-eluting stents (DES), which dramatically 
reduce the incidence of in-stent restenosis The diagnosis of left main is usually made by 
angiography. However, certain findings on exercise testing or, in patients with acute 
coronary syndromes on the ECG, are suggestive of left main disease. Coronary stents are 
widely used to overcome the limitation of  balloon angioplasty and may be useful for treating 
unprotected left main coronary artery (LMCA) stenosis. 
Stenting in distal LMCA bifurcation disease is technically  more complex than in ostial or 
shaft lesions.  
With drug –eluting stents, simple (i.e., extending the stent across the circumflex artery) or 
complex stenting techniques (i.e., multiple stent placement, such as kissing stenting, T 
stenting, or  crush technique) can be used for the treatment of bifurcation  LMCA lesions 
according to vascular size and lesion morphology. 
 In bifurcation LMCA lesions with a normal circumflex Artery, simple stenting 
strategy using a crossover technical may be a more effective strategy for reducing the 
restenosis rate than complex stenting techniques. 
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 Intravascular ultrasound is a useful adjunct in unprotected LMCA intervention to 
assess actual vessel size, disease extent of the main vessel and the side branch, and final stent 
optimization. 
 Routine use of debulking atherectomy is not recommended in drug- eluting stent 
implantation for unprotected LMCA stenosis. However, its selective role is being studied.  
 Although and intra – aortic balloon pump is not routinely recommended during the 
procedure, it should be considered for prevention of hemodynamic collapse in patients with 
severely depressed left ventricular function. 
 When patients with LMCA stenosis had well – preserved left ventricular systolic 
function and were good candidates for coronary bypass graft surgery, the procedural success 
rates and in hospital outcomes after the use of bare metal stents were favorable. 
 Use of drug eluting stents significantly decreased in stent restenosis when stenting 
was done for unprotected LMCA stenosis compared with the use of bare metal stents. 
 Ongoing randomized studies comparing the safety and efficacy of drug eluting stents 
with bypass surgery will determine whether stenting can be an alternative to bypass surgery 
in patients with unprotected LMCA stenosis. 
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 Left main coronary artery  (LMCA) stenosis has several causes . LMCA stenosis is 
considered an attractive target for balloon angioplasty because of the vessels large caliber, 
the lack of tortuosity, and the short lesion length. Histologically, the LMCA ha the most 
elastic tissue of the coronary vessels, accounting for  the poor response of the LMCA to 
simple balloon angioplasty. However, coronary stents have been shown to reduce the 
immediate need for coronary artery bypass surgery (CABG) for abrupt vessel closure and the 
likelihood of restenosis after balloon angioplasty. Newer devices are widely used to 
overcome the limitations of balloon angioplasty and may also be useful for treating 
unprotected LMCA stenosis in some patients. Stenting of unprotected LMCA stenosis if 
therefore considered a therapeutic option in selected patients. 
 
TECHNICAL CONSIDERATIONS IN UNPROTECTED LEFT MAIN 
CORONARY ARTERY STENTING  
Ostial lesions  
The ostial LMCA lesion is dilated and stented with the  tip positioned in the aortic sinus. The 
proximal end of the stent protrudes slightly to the left (1 to 2 mm) outside the ostium and is 
expanded against the aortic wall as in stenting of any aorto – ostial lesion. Predilatation  
before stenting is necessary and is usually performed with undersized, conventional 
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angioplasty balloons. The stent is then deployed by inflating the stent delivery balloon at a 
nominal or high pressure. After deployment of the stent, the stented segment is often dilated 
again using high – pressure for the balloon inflation to achieve angiographically confirmed 
optimal results. Stent size is selected based on the reference artery size and lesion length. 
Slotted – tube stents, rather than coil stents, are preferable for treatment of LMCA ostial 
disease because of their strong radial force. Balloon inflations should be brief (<30 seconds) 
and multiple (>3) to avoid prolonged global is ischemia and ischemia related complications. 
Shaft lesions  
 The lesions in the mid shaft of the LMCA can be pre dilated and then stented as done 
for any discrete lesion in other branches. As for ostial LMCA lesions, debulking is 
commenced in suitable lesion. 
 Approximately two thirds of all significant lesions in the LMCA involve the distal 
bifurcation. Stenting of distal LMCA bifurcation disease is the most technically complex and 
potentially high- risk anatomic variant of LMCA intervention. Distal LMCA bifurcation 
stenting should therefore be performed only by highly skilled interventionists. Patients must 
also be informed and must fully comprehend the risks and benefits of the percutaneous 
approach compared with surgical alternatives. 
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Balloon angioplasty of the distal LMCA bifurcation has been associated with a high rate of 
complications and restenosis. In the contrast, numerous reports suggest that stenting in the 
bifurcation lesion may result  in predictable short term outcomes with dreadful effects. Side 
branch occlusion due to plaque shifting during balloon angioplasty of a parent vessel is 
common, and in LMCA bifurcation stenosis, intervention may result in predictable short term 
outcomes with durable effects. Side branch occlusion due to plaque shifting during balloon 
angioplasty of a parents vessel is common, and in LMCA bifurcation stenosis, interventions 
may results in occlusion of the ostium of the left anterior descending artery (LAD) or left 
circumflex artery (LCX),  with disastrous clinical consequences. Various interventional 
techniques have branch occlusion in bifurcating coronary lesions. Plaque debulking with 
directional and rotational atherctomy has been proposed for bifurcation lesions to reduce 
plaque shift and side branch compromise. Many bifurcation stent techniques have been 
explored to prevent side branch occlusion including T stenting, reverse – Y stenting, trouser 
leg stenting, V stenting , culotte stenting, and crush stenting. No single interventional 
technique has been found to guarantee  preserved patency of the parent vessel and side 
branch. Bifurcation stenting (with or without debulking) is technically demanding, requiring 
considerable expertise. The complexity of these techniques depends on the specific anatomy 
of the bifurcation, the approach used, and the stents employed. There is no single optimal 
technical approach to LMCA bifurcation disease. Moreover because of the serious clinical 
consequences of major side branch occlusion during LMCA bifurcation stenting, not all 
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interventionists agree that percutaneous interventions for LMCA  bifurcation stenosis is 
warranted. 
 At the Asan medical center, stenting for LMCA bifurcation stenoses was performed 
in selected patients between November 1995 and march 2002 80 consecutive patients with 
unprotected LMCA bifurcation lesions underwent stent placement. Stenting was larger 
performed with or without debulking atherectomy at the operators discretion. If the artery 
was larger than 3.0 mm in diameter and had no calcification, directional coronary 
atherectomy (DCA)was usefully performed using a 7 Fr catheter. Rotational atherectomy 
using a step burr approach was performed for calcified lesions. Four major stenting strategies 
were used, determined by the specific lesion characteristic and anatomy of the distal LMCA 
bifurcation, including crossover stenting of the LCX, T(Y) stenting, kissing stenting and 
bifurcation stenting. 
 
Methods of stenting  
Crossover technique  
Tube stents may be deployed from the LMCA to the proximal portion of LAD if the LCX is 
diminutive (<2.5mm) or normal (diameter of stenosis <50%). After stent placement, the LCX 
is dilated through the first implanted stent strut, as necessary . in the study park and 
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colleagues, the LCX ostium was typically covered by a stent without risk of occlusion if it 
was diminutive or normal. Fifty – four percent of patients were successfully treated with 
stent placement across the LCX ostium, suggesting that this technique may be widely used 
for treatment of LMCA bifurcation lesions. However, progression of disease in the side 
branch lesion spanned by a stent may be difficult to treat, and a possible risk of side branch 
occlusion remains an important limitation of this strategy. 
T or Y stenting with or without simultaneous kissing stenting  
 T or Y stenting with or without simultaneous kissing stenting is performed if the LCX 
is large and has significant ostial disease. In the bare metal stent (BMS) era, in the T 
technique (or Y technique, depending  on the angle of the bifurcation), after coil stenting (or 
open – cell design ) from the LMCA to the LCX, a slotted – tube stent was sequentially 
implanted into the LAD through the struts of the coil stent . 
 The efficacy of T stenting was challenged in the era of the drug – eluting stent (DES). 
The study of the sirolimus – Eluting stent in the Treatment of patients with long de novo 
lesions in small native coronary arteries (SIRIUS bifurcation study) was a multicenter, 
randomized trail to asses the feasibility and safety of sirolimus – eluting stent (SES) 
implantation for bifurcation lesions. In this study, 22 of 43 patient assigned to single SES 
implantation in the main vessel (group B) were crossed over to T stenting with two SESs, 
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implanted in the main vessel and the side branch (group A) because of flow impairment or 
residual stenosis of more than 50% of the diameter of the side branch after stent implantation 
in the main vessel. Sixty – three patients were treated with single stent implantation. 
Although the high number of crossover patients has made direct comparison of the two 
groups difficult, the restenosis rates for the two treatment groups were comparably very low 
(2.3% in group A versus 5.0% in group B). the use of a second stent did not improve the 
restenosis rate of the side branch (19.2% in group A versus 21.1% in group B, p= NS). 
Overall, the restenosis rate for group A was higher than for group B (25.0% versus 10.0%, 
p=.20). but it did not achieve statistical significance. The investigators of this study 
postulated that the relatively high restenosis rate at the side branch in the two – stents 
implantation group was caused by incomplete coverage of the bifurcation using the T 
stenting technique. They suggested that T stenting might leave a gap between the two stents 
at the bifurcation. Other techniques, such as the crush technique of kissing stenting, have 
been introduced to overcome the problem of T stenting. 
Kissing stenting  
 Kissing stenting is also a two stent implantation technique similar to kissing balloon 
inflation. A minimum 8 Fr guiding catheter is needed for this technique.  The two stents are 
deployed simultaneously, which creates a double lumen in the main vessel proximal to the 
bifurcation site. Adjunctive sequential alternative balloon dilatation with final kissing balloon 
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dilatation may be required for optimal stent expansion, especially in the distal part of the 
bifurcation. This technique is useful for bifurcation lesions with two large side branches with 
a large diameter of the LMCA trunk. Park suggested that this technique would be appropriate 
in treating large LMCA lesions (>4.5mm). a practical concern of this technique is the 
difficulty of re-accessing both branches in case of rest enosis. However, in the era of DES 
implantation as one of the appropriate stenting techniques for LMCA bifurcation lesions with 
a very proximal vessel. This technique is very safe because access to both branches is always 
maintained, and it allows complete lesion coverage quick performance and easy execution 
are the major advantages for this technique. 
Bifurcation stenting with side branch access stenting 
The AST SLK – View bifurcation stent (advanced stent technologies, san Francisco, CA) 
was designed to preserve side branch access and complete the bifurcation stent procedure. the 
AST SLK – View stent consists of a stainless steel stent with a widened section in the struts 
located between the proximal and distal ends. A side branch wire exit port passes through 
this hole, allowing access to the side branch after stenting the main branch. The AST SLK – 
view stent represents an main branch an attractive new approach for treatment of bifurcation 
lesions. However, further studies are needed to compare this stent with conventional stents 
for treatment of LMCA bifurcation lesions. Preliminary efficacy of this stent system, 
including outcomes for 11 cases of LMCA bifurcation stenosis, has been presented. In this 
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study, the binary restenosis rates at the 6 months follow up evaluation were 28.3% and 37.7% 
for the main vessel and the side branch, respectively. 
Crush technique 
The crush technique was introduced by Colombo and colleagues. With the use of DESs, this 
techniques has several advantages. The crush techniques ensures the complete 
circumferential coverage of the side branch ostium. A practically advantages is that the 
techniques is quite safe and relatively simple to execute. This approach gives an immediately 
successfully results with patency of both branches without special technical maneuvers. An 
important concern about this technique is whether the traditional final kissing balloon 
dilatation is required. Colombo and colleagues suggested that final kissing balloon inflation 
is very important to achieve long – term patency. Ormiston and coworkers supported the idea 
with the use of a phantom model. This study demonstrated that is important to postdilate both 
stents with appropriately sized balloons. One study achieved a 49% relative reduction in the 
restenosis rate in the side branch by routine use of final kissing balloon dilation compared 
with the results of the SIRIUS bifurcation study. the significant reduction of late lumen loss 
in the side branch after kissing balloon dilation can be explained by better strut contact with 
the vessel wall and better drug strut contact with the vessel wall and better drug delivery. 
Kissing ballon dilation may also correct stent deformation and ensure optimal stent 
scaffolding. 
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Adjunctive Devices in Unprotected Left Main Coronary Artery Stenting 
Intravascular Ultrasound 
 Although intravascular ultrasound (IVUS) provides unique quantitative and 
qualitative information on coronary artery lesions, the impact of IVUS on long term clinical 
outcomes after stent implantation has been controversial. The can routine ultrasound 
influence stent expansion (CRUISE) study demonstrated that IVUS –guided stent 
implantation in non-LMCA lesions ensures more effective stent expansion and a larger 
minimal stent area, resulting in less frequent target vessel revascularization. These results 
may apply to LMCA intervention as well for several reasons. It is often difficult to evaluate 
the actual size of the LMCA by angiography. The left main trunk often is short and lacks a 
normal segment for comparison. Contrast blowback in the aortic cusp may obscure the 
ostium, and streaming of contrast may result in a false impression of luminal narrowing. 
Angiography may underestimate stenosis severity, because diffuse disease in the proximal 
and distal reference segments adjacent to a focal stenosis may be interpreted as normal 
dimensions, leading to stent undersizing. Preinterventional IVUS examination also provides 
important information about the underlying lesion morphology and may guide treatment 
strategy, especially in helping to decide when debulking is necessary or is complete. 
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Angiographically unapparent severe calcification may be seen by IVUS, leading to the 
decision to performed high-speed rotational atherectomy before stenting to maximize stent 
expansion. Moreover, negative remodeling (defined as an external elastic membrane cross-
sectional area at the lesion site that is smaller than that of the distal reference segment) may 
be documented in 91% of patients undergoing IVUS-guided stenting of ostial LMCA lesions. 
in such cases; in which plaque volume is actually reduced compared with non-remodeled or 
positively remodeled vessels, debulking is unnecessary, and stenting along should be 
performed. 
Table: Advantages to Intravascular Ultrasound before and during Left 
Main Coronary Artery Intervention 
Provides precise quantitative measurement 
Reference vessel diameter 
Minimal luminal diameter (before and after) 
Lesion cross-sectional area (before and after) 
Lesion length (automatic pullback) 
Characterization of plaque  
Arterial remodeling (positive, negative) 
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Plaque stability vs. rupture 
Plaque distribution (eccentric, concentric) 
Plaque composition (soft, fibrous, calcified, mixed; depth of calcium) 
Dissection after predilatation and stenting (length, severity of lumen compromise) 
Accurate guidance of procedure 
Decision about additional ballooning  
Decision about treatment strategy in intermediate lesion by quantitative coronary 
angiography 
Decision about debulking procedure 
Evaluation of stent expansion 
Evaluation of apposition 
 Performance of IVUS before and during stenting in LMCA stenoses may provide 
useful information for the selection of the appropriate diameter of balloons and stents, as well 
as the accurate amount and extent of calcification and need to debulk. Such information has 
resulted in changes in the planned procedure and treatment modalities for approximately 40% 
of non-LMCA lesions. IVUS may also help differentiate which borderline lesions require 
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intervention (with stenting or surgery). However, there are no absolute ultrasound criteria for 
intervening in a “critical” LMCA stenosis. Important considerations include the patient’s 
symptom status, the presence of other lesions, and the amount of myocardium in jeopardy. 
Nevertheless, suggested IVUS criteria for significant LMCA disease are stenosis of more 
than 50% of the vessel diameter, stenosis of more than 60% of the area, and an absolute 
cross-sectional area less than 7mm2 in symptomatic patients or less than 6mm2 in 
asymptomatic patients.   
 One study evaluated 122 patients with intermediate LMCA disease (=42% diameter 
stenosis assessed by quantitative coronary angiography). The 1 year event rate was 14% 
when LMCA revascularization was deferred based on IVUS findings. When patients with an 
event were compared with patients without an event, there were no significant differences in 
left ventricular function or the angiographic diameter stenosis, but the group with events had 
greater cross-sectional narrowing (70% + 14% versus 53% + 18%, P=.04), smaller minimum 
LMCA lumen area (6.8 + 4.4 versus 10.0 + 5.3mm2, P=.01), and smaller minimal lumen 
diameter (MLD) (2.30 + 0.69 versus 2.94 + 0.81 mm, P = .001). Predictors of cardiac events 
at 1 year were diabetes mellitus (OR = 6.32; 95% CI: 1.82 to 22.04; P=.004), any epicardial 
vessel with an angiographic stenosis of 50% or more as assessed by quantitative analysis 
(3.80 [1.08 to 13.39]; P = .037), and the LMCA MLD as assessed by IVUS (or = 0.17[CI: 
0.05 to 0.59]; p= .005). when IVUS is used to assess the severity of intermediate LMCA 
stenoses, decisions to defer to revascularization must consider absolute IVUS dimensions, 
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the presence of diabetes, and the presence of significant lesions in other major epicardial 
vessels.  
 The Asan medical center reported their experience in stenting 127 unprotected 
LMCA lesions with (n=77) or without (n=50) IVUS guidance. Debulking procedures before 
stenting were more frequently performed in the IVUS guided group (39% versus 20%, 
p=.02), primarily because of identification of severe calcification with a circumferential arc 
of more than 90 degree after IVUS evaluation. According to the IVUS criteria of stent 
optimization, additional high pressure balloon angioplasty was performed in 15 (19.5%) of 
the 77 lesions. As a consequence, the postintervention minimal stent cross- sectional area 
increased from 10.7+- 2.8mm to 13.0+-4.0 mm after additional balloon angioplasty. The final 
lumen diameter after stenting was significantly larger in the IVUS guided group as assessed 
by quantitative coronary analysis (4.2+-0.6 versus 4.0+-0.6 mm, p=.003) . However, the 
angiographic restenosis and target lesion revascularization rates were not different between 
the IVUS guided and angiography guided procedures in this study. This finding may be 
explained partly by the fact that the reference vessel  size in the current series was large (>4.0 
mm) and that the post stent MLD was large (>4.0 mm), even in the angiography guided 
group. A post stent MLD of more than 4.0 mm should be large enough to prevent binary 
restenosis at follow up. However, we continue to believe that IVUS guidance of unprotected 
LMCA lesion stenting should be considered, because optimal stent expansion and apposition 
(which can be verified only by IVUS) may prevent stent thrombosis in the LMCA, a 
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complication with a potentially fatal outcome. In a single center, a small study evaluating the 
impact of IVUS on unprotected LMCA intervention showed that the incidence of major 
adverse events was similar : 2(8%) of 24 in the IVUS group and 7 (20%) of 34 in the non 
IVUS group (p=.18). however, IVUS evaluation may be crucial in unprotected LMCA 
intervention for lesion assessment, which facilities selecting performing optimal stenting 
strategy. 
Debulking atherectomy  
 Debulking with directional or rotational atherectomy  does not completely eliminate 
acute recoil and active vessel remodeling after directional. The angio graphic restenosis rate 
after directional atherectomy  was found to be similar to that of balloon angioplasty alone 
despite a smaller post procedural, however optimally deployed coronary stents  the rate of 
restenosis compared with balloon angioplasty (or directional atherectomy) alone by 
preventing acute elastic recoil and negative chronic remodeling (although neointimal 
hyperplasty increased). Debulking combined with stenting compared with stenting alone may 
result in a postprocedural lumen gain and subsequently angiographic restenosis. Studies have 
shown that residual plaque burden is an important predictive intimal hyperplasia in stented 
lesions and aggressive debulking with directional atherectomy before stenting might reduce 
the residual plaque burden and subsequently reduce the extent of restenosis. This combined 
approach therefore may be optimal approach for the management of unprotected LMCA 
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stenosis with a large plaque burden the asan medical center, debulking especially  is 
performed before stenting if the lesion is suited rotational atherectomy before stenting is also 
performed if the plaque has diffuse superficial calcification. At the Asan Medical Center, the 
degree debulking using directional atherectomy was compatible with that of other reports 
(e.g stenosis after Optimal Lesion Debulking [SOLD] Registry compared with stent 
implantation without atherectomy, debulking before stenting in unprotected LMCA lesions 
was associated with a significant restenosis of angiographically confirmed restenosis target 
lesion revascularization as assessed by  analysis the reduction in the rate of restenosis was 
most striking in LMCA ostial stenosis. However debulking atherectomy was not an 
independent predictor of freedom from restenosis as assessed by multivariate analysis. The 
most likely explanation is that because of the limited atherectomy device size, the degree of 
debulking achieved may be insufficient in large LMCA vessels. (i.e., mean reference vessel 
diameter of 4.0 mm). in the non debulking group it was possible to achieve just as large and 
MLD by high pressure balloon inflations.  
 DCA may facilitate successful stent placement by removing the plaque and may 
reduce restenosis rate by improving acute results. A nonrandomized study using BMSs 
showed that debulking before stenting resulted in significant reduction of angiographic 
restenosis. (p= .049) as assessed by univariate analysis. Hu and associaties found similar 
results for 67 low to high risk patients with unprotected LMCA stenosis with distal 
bifurcation involvement treated with IVUS guided directional atherectomy. The all cause 
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mortality, angiographic restenosis, and target lesion revascularization rates at 6 months were 
7%, 24% and 20%, respectively. However it is unknown whether debulking atherectomy 
would be advantageous in the era of DES implantation. In practice the use of debulking has 
been decreased by the remarkable reduction of restenosis by DESs. Additional research on 
the effects of DCA and DES implantation is warranted. 
Intra aortic Balloon Pump 
 Patients with normal left ventricular function are tolerant of global ischemia during 
balloon occlusion although the intra aortic balloon pump is not routinely recommended 
during the procedure, it should be considered for prevention of hemodynamic collapse in 
patients with severely depressed left ventricular function. 
BARE METAL STENT IMPLANTETION FOR UNPROTECTED LEFT MAIN 
CORONARY ARTERY STENOSIS. 
 With the explosive growth of coronary stenting in the 1990sintervention in the 
diseased LMCA was again attempted The results of these series demonstrated that when 
patients with LMCA stenosis had well – preserved left ventricular systolic function and were 
good candidates for bypass graft surgery, the procedural success rates and in hospital 
outcomes after stenting were favorable. 
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Unprotected left main trunk intervention 
 A multicenter registry of 107 patients from 25 centers was used to examine the 
procedural safety and the midterm outcomes of patients who may be considered for 
percutaneous intervention of unprotected LMCA stenosis. Stents were used in 50% 
directional atheractomy in 24%, balloon angioplasty in 20% and rotational atherectomy in 
6% of patients. Technical success was achieved in 96.4% of cases, but 20.6% of a patients 
died while in the hospital, and 10% had nonfatal Q- wave myocardial infarctions (MIs). After 
post – hospital discharge, outcomes were also unfavorable. Left ventricular function was the 
most important determinant of survival after LMCA intervention. The unprotected left main 
trunk intervention multicenter Assessment (ULTIMA). Registry data are difficult to interpret 
because of inclusion of a very heterogeneous group of patients, including those with poor of 
good left ventricular function, various degrees of severity of coronary artery disease, and 
different types of intervention used. 
 The ULTIMA registry was extended to 279 patients undergoing percutaneous 
intervention of unprotected LMCA stenosis between july 1993 and july 1998 to examine 
which patients might have favorable outcomes. Forty six percent of these patients were 
deemed inoperable of high risk surgical candidates. Thirty eight patients (13.7%) died in the 
hospital, and the remaining patients were followed for a mean of 19 months. The 1 year 
incidence of all cause mortality was 24.2% (with 20.2% cardiac mortality), with a 9.8% rate 
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of bypass surgery. By multivariate analysis, the independent correlates of death during and 
after hospitalization were left ventricular ejection fraction of 30% or less grade 3 to 4 mitral 
regurgitation, clinical presentation of MI with cardiogenic shock, serum creatinine level of 
2.0mg/dl or higher, and severe lesion calcification . decreasing left ventricular ejection 
fraction was inversely related to events in a nonlinear fashion, with an apparent inflection 
point at 30%. Except for lesion calcification the predictors of cardiac death were similar 
although different in magnitude: mitral regurgitation grade 3 or 4 (hazard ratio [HR] = 5.0); 
left ventricular ejection fraction of 30% or lower (HR = 4.9); MI with cardiogenic shock (HR 
= 4.8; and serum creatinine level of 2.0 mg/ dL or higher (HR=3.2). on the basis of this 
analysis, 32% of the patients could be identified with three clinical features: age younger 
than 65 years left ventricular ejection fraction of 30% or more and absence of cardiogenic 
shock from acute MI; they comprised a low risk group with a 3.4% 1 year mortality rate after 
LMCA intervention and a 2.3% risk of MI . there were no periprocedural deaths in this 
subgroup, and there were no additional deaths or MIs beyond 4 months after discharge (up to 
35 months). During the 1 year follow up of this low risk group, 24.5% of patients required 
additional revascularization procedures including repeat percutanenous intervention in 20.4% 
and bypass surgery in 11.4% Similar data were reported by silvertri and colleagues, who 
defined a low risk group as younger than 75 years with no prior bypass great surgery with a 
left ventricular ejection fraction of 35% or higher and with the absence of renal failure for 
these patients the 1 Year mortality rate after unprotected LMCA stenting was 7% and the 
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need for revascularization was 28%. To put these data in perspective, the in hospital 
mortality rate of patients with LMCA disease undergoing bypass graft surgery was 3.9% as 
reported by the Cleveland clinical Foundation, with a 1 year mortality rate of 11.3%. In the 
latter report, the 1 year morality rate after bypass surgery. For a low risk group similar to that 
defined in ULTIMA (age < 65 years with New York Heart Association congestive heart 
failure class < 2) was 5.7%. patients with well preserved systolic ventricular performance 
may have acceptable outcomes after LMCA stenting. 
Experience of the Asan Medical Center 
 The initial report from the ULTIMA Registry demonstrated a relatively high short 
term cardiac mortality rate of a heterogeneous group of patients. Many of these patients were 
high risk or ineligible for bypass surgery, and left ventricular ejection fraction was directly 
related to early and late survival. In the Asan Medical Center experience as reported by park 
and associates, only patients with a left ventricular function of 40% or higher were 
considered for LMCA intervention. 
 Until January 2001, unprotected LMCA stenting was performed in 156 consecutive 
patients with normal left ventricular function. The procedural success rate was 99.1% and 
13% underwent multivessel angioplasty during the intervention. There were no procedure 
related deaths. However, one patients developed a coronary perforation after DCA, which 
  
 
34 
 
was successfully treated with a stent graft. During the hospital stay, angiographically 
documented stent thrombosis occurred in one patient (0.6%) at 3 days after intervention and 
was complicated by a Q –wave acute MI and the need for elective bypass graft surgery 30 
days later. For the remaining patients, the in hospital clinical outcome was uneventful. 
Angiographic follow up data were obtained for 100 of 104 eligible patients (96%) Restenosis 
was angiographically documented in 19 patients (19%). In the Asan Medical Center study, 
when restenosis developed after stenting, it required repeat revascularization, typically within 
6 months, and thereafter, most patients were free of symptoms without major adverse cardiac 
events. 
As expected, a smaller reference vessel size was related to a greater likelihood of 
restenosis, because late lumen loss may be greater in stents implanted in large vessels. As in 
previous studies of non LMCA lesions and protected LMCA stenting, the post stent MLD 
and minimal lumen cross sectional area as assessed by IVUS were the most powerful 
predictors of angiographic restenosis. Target lesion revascularization at the 2 year follow up 
was independent of lesion location within the LMCA as assessed by univariate analysis, there 
were trends for lower restenosis rates in patients undergoing debulking and in those 
achieving was the only independent predictor of angiographically observed restenosis in the 
study. The angiographically confirmed restenosis rate was statistically higher in vessels with 
a reference diameter of less than 3.6  mm. this cutoff level of 3.6  mm is an arbitrary lower 
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threshold. Although the 31% restenosis rate for these vessels may be slightly higher than that 
expected in non LMCA stenting for similar sized arteries, it still is acceptable. 
 The results to LMCA bifurcation stenting from the Asan Medical Center were 
published in 2002. Sixty three consecutive patients were included.DCA was performed in 32 
patients (51%). The procedure was successful in all patients, and a prophylactic intraaortic 
balloon pump was used in only two patients. In hospital events did not occur for any patient. 
Angiographic follow-up was performed for 43 (86%) of the 50 eligible patients reaching the 
6 month follow up point. The angiographic restenosis rate was 28% (including the parent 
vessel only [LMCA to LAD], 14%; LCX only, 9%; and both, 5%). Restenosis in the parent 
vessel occurred less frequently in the debulking group than in the non-debulking group (5% 
versus 33%, P=.02). Smaller reference vessel diameter and not having performed debulking 
were significant univariate predictors of restenosis in the parent vessel, but debulking was the 
only independent predictive factor for freedom from restenosis (OR=0.10; 95%, CI: 0.01 to 
0.90; P=.04). No factors were predictive of restenosis at the side branch. Mean follow-up 
duration was 19.9 + 13.7 months (range, 0.23 to 64.6 months). There were low noncardiac 
deaths but no instances of MI during follow-up. Target lesion revascularization was 
performed in 6 patients (10%), including repeated percutaneous intervention (n=5) and 
bypass surgery (n=1). The event free survival rate was 86% + 6%. In this study, DCA might 
have been useful for treatment of LMCA bifurcation lesions because a large plaque burden 
was usually present, and debulking might have prevented plaque shift. 
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Experience of the ULTRA Registry 
 The unprotected left main trunk, angioplasty (ULTRA) study was a multicenter, 
prospective registry of patients undergoing emergent or elective percutaneous coronary 
intervention (PCI) for unprotected LMCA stenoses (n=284), which was performed in Japan, 
and the results were presented at the complex Catheter Technique meeting in Japan in 2002. 
This study included very-high-risk patients, including those with acute MI (17%) and 
patients undergoing emergent intervention for acute coronary syndromes (35%). Coronary 
stenting, DCA, and other techniques (including conventional balloon angioplasty, cutting 
balloon angioplasty in acute MI were very poor, as expected, with a clinical success rate of 
64% and an in hospital mortality rate of 34%. Patients without acute MI, however, had 
excellent initial and long term outcomes. In these patients, procedural success was achieved 
in 99.6% of patients, and major in hospital complications (i.e., death, Q-wave MI, and 
emergent bypass surgery) occurred in only 6% of patients. In patients undergoing elective 
intervention for LMCA disease (n=183), the major in hospital complication rate was only 
1%. During 30+11 months of follow up, the restenosis rate was 22% and the 1 year  event 
free survival rate was 89%. These very good initial and long term outcomes are similar to 
those of other studies of stenting for low risk patients with unprotected LMCA stenosis. 
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Experience of the Multicenter European Study 
 Black and associates reported the results of stenting unprotected LMCA stenoses in 
92 patients from Australia and France. Angiographic success was achieved in 100% of 
patients, and the mean final stent diameter was 3.9+0.51 mm. Four (4.3%) procedure-related 
deaths occurred. Neither MI nor emergency bypass surgery occurred during the index 
hospitalization. During follow up (7.3+5.8 months; median, 239 days; range, 49 to 1477 
days), there were six additional deaths (6.5%): one sudden death was presumed to have a 
cardiac cause, one was caused by ventricular arrhythmia, three patients died of congestive 
heart failure, and there was one noncardiac death from lung cancer. The Kaplan-Meier 
survival estimates found 500- and 1000-day survival estimates of 89% and 85% respectively. 
Of the 82 (89%) patients surviving at 6 months, 4 had symptomatic LMCA restenosis and 
were treated by repeat balloon angioplasty within the stent, Nine other patients had repeat 
percutaneous intervention in other vessels, and two patients had bypass surgery for restenosis 
(one for LMCA disease, one for LAD disease). The results differed dramatically, depending 
on whether LMCA stenting was performed in patients in whom bypass surgery was or was 
not contraindicated (i.e., high and low risk groups, respectively). The total mortality rate at 6 
months was significantly higher for patients who were not candidates for bypass graft 
surgery (20.5% versus 3.8%, P<.02). The final stent MLDs and diameters of stenoses were 
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predicative of mortality by univariate analysis. Lower left ventricular ejection fraction and 
the presence of three-vessel coronary artery disease also tended to be more common in 
patients who died of cardiac causes.  
 
  Silvestri and coworkers also examined the outcomes of low risk patient 
(n=93) and high risk patients (n=47) after LMCA stenting. The high risk group was 
composed of patients who were older than 75 years, had history of heart surgery, had a left 
ventricular ejection fraction less than 35% had renal failure, had inadequate distal coronary 
runoff, or had severe respiratory failure. The mortality rate at 1 month was 7% for the high 
risk group of patients and 0% for the low risk group. However, the rate of freedom from 
major adverse cardiac events at I year was similar for the two groups (66% in high risk group 
versus 72% in low risk group, p=NS). 
Experience of the French multicenter registry  
 Lefevere presented the French data comparing coronary intervention (n=193), bypass 
surgery (n=233), and medical treatment (n=57) for LMCA stenoses at the complex catheter 
Technique meeting in Japan in 2002. Eleven centers in france enrolled 483 patients older 
than 75 years, with pulmonary failure, renal failure, severe peripheral disease, previous 
bypass graft surgery, previous stroke, and left ventricular ejection fraction less than 30%. 
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Coronary intervention, bypass surgery, or the patients discretion. High risk patients were 
more common in the coronary intervention group than in the bypass surgery group (45% 
versus 14%), although triple vessel disease was more common in the surgery groups (53% 
versus 68%). The in hospital mortality rate was higher after surgery than after coronary 
intervention (3.8% versus 0%, p<.001). at the 6 month follow up evaluation, the rates of 
mortality (6.4% with coronary intervention versus 8.1% after surgery) and MI (1.6% versus 
1.6%) were similar in the two groups. However, the rate of the repeat revascularization of the 
LMCA was higher in the angioplasty group than the surgery group (15.2% versus 2.7%, 
p=.04). although these data were not from a randomized , controlled study, the result suggest 
that LMCA stenting may have comparable long term results in terms of freedom from death 
or MI compared with bypass surgery. These favorable initial and intermediate term outcomes 
of LMCA stenting for low risk patients (who would otherwise be candidates for bypass graft 
surgery) suggested the feasibility of unprotected LMCA stenting. 
APPROACH IN STENT RESTENOSIS OF THE UNPROTECTED LEFT 
MAIN CORONARY ARTERY 
In stent restenosis of the LMCA remains a challenging problem. Because unrecognized 
LMCA restenosis can manifest as cardiac death, most groups perform unprotected LMCA 
stenting recommends elective angiographic restudy at 4 to 6 months after stenting. Elective 
bypass graft surgery is usually recommended for the treatment of in stent restenosis of the 
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LMCA. Prior stenting in the LMCA does nor interfere with subsequent CABG, and it is the 
gold standard for the treatment  of LMCA stenosis. Alternatively, repeated  percutaneous 
interventions using rotational atherectomy or radiation therapy, or both in selected patients 
who refuse surgery have been performed successfully. Further studies and follow up are 
needed. The role of drug- eluting stents for treating LMCA in stent restenosis after bare metal 
stenting has not been reported. 
ELECTIVE INTERVENTION FOR PROTECTED LEFT MAIN 
CORONARY ARTERY STENOSIS 
 Over the past 25 years, bypass surgery has provided excellent short term and long 
term clinical results for patients with LMCA disease, and the treatment of this lesion has 
therefore largely remained in the province of the cardiovascular surgeon. However LMCA 
stenosis often require treatment after bypass surgery disease of bypass graft failure. In most 
cases, a bypass graft is patent to the LAD or to the LCX (or one of their respective branches), 
resulting in intervention being required for a protected LMCA lesion; the implication is that 
such a procedure is lower risk than in an unprotected LMCA lesion because ischemia due to 
LMCA occlusion does not compromise a large portion of the left ventricular myocardium, 
conventional balloon angioplasty is often ineffective for a heavy plaque burden and 
calcification in the unprotected (or protected) LMCA lesion. However, several studies have 
shown that stenting a protected LMCA stenosis can be safely performed with a high success 
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rate and favorable clinical outcomes  Kornowski and coworker reported that stents reduce 
major in hospital complication but might not significantly reduce repeat revascularisation of 
major cardiac events at 1 year compared with nonstent LMCA procedures. In their study, 
diabetes mellitus (OR=3.2, P=.04) independently predicated target lesion revascularization, 
and the final lumen diameter (OR=0.3, P=.017) was negatively associated with target lesion 
revascularization. Nevertheless, the use of stents, alone or after initial rotational atherectomy, 
produces the best immediate angiographic results. Technical considerations are similar to 
those for unprotected LMCA intervention, and precise positioning of the stent is critical, as 
described previously. although  not proved. 
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        AIM AND OBJECTIVES OF THE STUDY 
 
The purpose of the study was the utility of transesophageal echocardiography in assessing 
left   main coronary artery stenosis  
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Materials   and methods:  
 The  study  was  conducted  in  the   department   of cardiology  Government Rajaji  
Hospital  Madurai  between  Jan  2009  to   April 2010.All patients  underwent  
Coronary   angiogram   &Transesophageal echocardiography   was   done   and   left   main  
coronary  artery   visualized  at midesophageal transverse view at base of the heart and at the 
level of left sinus of valsalva and flow was recorded with pulsed wave Doppler.  
                                                            Methods  
Study group  
Fifty patients with a left main coronary artery (LMCA) stenosis  were prospectively studied 
from January2009 to April2010. We chose patients with LMCA  because, TEDE recordings 
are easier to obtain in these portions of the LCA. A high quality TEDE signal was obtained in 
50 patients (45 men and 5 women, mean age 53 years [range 36 to 70]). Written informed 
consent for TEDE examination was obtained in all patients. 
Coronary angiography and quantitative coronary angiography  
Coronary angiography was performed using the standard Judkins method with the femoral 
artery approach. Coronary injections were performed using multiple views, and images were 
recorded on  TOSHIBA  flat panel direct digital acquisition system . This quantitative 
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coronary angiographic system has been validated previously (16). Quantitative analysis of 
stenosis was performed using the average of results obtained from two orthogonal 
projections, when available, or the most severe narrowing of several nonorthogonal 
angiographic projections. Three recognized quantitative variables of stenosis severity 17., 18. 
were automatically computed by the  software: percent diameter stenosis (DS), minimal 
lumen diameter (MLD) and percent CSA stenosis. 
Transesophageal Doppler echocardiographic measurements  
Transesophageal echocardiography was performed with a 7-MHz probe connected to a 
Philips IE33 echocardiographic system within 24 h of the angiographic study. A multiplane 
probe was used in all patients. Transesophageal examination was performed in each patient 
after  oropharyngeal anesthesia by lidocaıሷne. The LMCA was visualized by placing the 
transducer just above the aortic leaflets. Small adjustments in transducer orientation were 
necessary to visualize the bifurcation of the vessel into the LAD and circumflex artery.The 
length ,diameter of LMCA (at the level of ostium,shaft and distal LMCA)were measured. 
Prestenotic and transstenotic coronary flow velocities were then measured as follows: 
coronary blood flow was first visualized by color flow imaging and a localized color aliasing 
phenomenon corresponding to a local flow acceleration was searched; pulsed wave Doppler 
echocardiography was then sampled in the site immediately upstream from the area of color 
aliasing; second, the sample volume was moved slightly downward in the area of color 
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aliasing. High pulse repetition frequency or continuous wave Doppler echocardiography was 
used to quantitate the magnitude of transstenotic velocities if these velocities were too high to 
be measured by pulsed Doppler echocardiography without aliasing,. Small adjustments in the 
transducer orientation allowed alignment of the ultrasound beam with the long axis of the 
interrogated proximal portion of the LCA. The peak flow–velocity curve was traced from the 
outer border of the Doppler spectral signal, and the time–velocity integral (TVI) was 
obtained by planimetry as the area under this peak flow– velocity curve during diastole.other 
investigators have previously reported good interobserver and intraobserver reproducibility 
of coronary flow transesophageal Doppler velocity recording in the proximal part of the LCA 
9., 10., 11., 12., 13., 14., 15..  
The  parameters assessed in T.E.E are 
 a) Diameter of LMCA at ostial level, shaft level, at the level of bifurcation 
b)Length of left main coronary artery 
c)Presence of atheroma. 
d)Presence of turbulence 
e)  Diastolic flow velocity before level of stenosis,at the  level  of  stenosis,and  after  the  
level  of   stenosis. 
f)TVI before the level of stenosis and at the trans stenotic level were measured.  
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                                                           Statistical analysis 
All data are expressed as the mean value ± SD The information collected regarding 
all the selected cases were recorded in a Master Chart. Data analysis was done with the help 
of computer using Epidemiological Information Package (EPI 2008) developed by Center 
for Disease Control, Atlanta.  
 Using this software, range, frequencies, percentages, means, standard deviations  
and ‘p’ values were calculated. A ‘p’ value less than 0.05 is taken to denote significant 
relationship. 
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OBSERVATIONS 
 Table 1.: Age 
Age group 
( in years) 
Cases 
            (no) 
 
% 
Up to 40 years 
4 8 
41-50 yrs 
16 32 
51-60 yrs 21 42 
> 60 yrs 9 18 
Total 50 100 
Range 36 – 70 years 
Mean 53.3 years 
SD  8.1 years 
AGE DISTRIBUTION 
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Table 2 : Sex distribution 
Sex 
Cases 
No % 
Male 
45 90 
Female 5 10 
Total 50 100 
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Table 3.: Diagnosis 
Diagnosis 
Cases 
No % 
Stable Angina 
11 22 
Unstable Angina 
6 12 
AWMI 17 34 
IWMI 14 28 
PWMI 1 2 
Old IWMI 1 2 
Total 50 100 
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Table 4 : D M 
D M 
Cases 
No % 
Yes 
15 30 
No 35 70 
Total 50 100 
 
D M 
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Table 5:  LVID & LVEF 
PARAMETER Mean + S.D 
Range 
LVID(D) 5.1+0.67 3.5 – 7.1 
LVID(S) 3.8+0.86 1.9 – 6 
LVEF(T) 46.5+13.9 17 – 73 
LVEF(QLAB) 44.7+11.3 25 - 73 
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Table 6 : E / A / DT 
 
 
Parameter Mean +S.D Range 
E 64.2+15.4 36 – 110 
A 61+10.9 27 – 79 
DT 139+33.5 56 - 238 
 
E / A / DT 
 
 
 
 
 
 
 
 
 
0
20
40
60
80
100
120
140
E A DT
64.2 61
139
  
 
53 
 
Table 7 :  Correlation between Echo findings and Angiogram findings 
Parametetr 
Values as per  
Correlation 
Coefficient 
Between 
Echo and 
Angiogram 
values 
Echo Angiogram 
 
Range 
 
Mean 
 
S.D. 
 
Range 
 
Mean 
 
S.D. 
LMCA(L) 3.9-18.8 10 3.2 4.5-22 11.5 4.2 0.7137 
Diameter(O) 2-6.9 3.78 1.12 0.96-5.31 3.28 0.84 0.3562 
Shaft 1.7-5.2 3.5 0.97 1.4-5.03 3.04 0.89 0.0267 
Bifurca 1.3-6.3 2.99 0.87 1.11-4.37 2.54 0.84 0.3817 
% Stenosis     12-89 47.8 19.1 20-90 43.2 15.7 0.6007 
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% STENOSIS(ECHO) 
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% STENOSIS(ECHO) 
& % STENOSIS(ANGIO) 
 
 
 
 
 
 
 
 
 
 
 
Table 8 : TVI (BEFORE)  & TVI (AFTER)  STENOSIS 
PARAMETER 
TVI(BEFORE) TVI(AFTER) 
Range 
5-53 12-103 
Mean 
25.2 51.8 
S.D. 
11.4 21.4 
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TVI(BEFORE) & TVI (AFTER)STENOSIS 
 
 
 
 
 
 
 
 
 
 
Table 9 :   Relationship between pre/post TVI and % Stenosis as per Angiogram findings 
Pre / Post TVI No. of cases 
% Stenosis as per Angiogram 
< 50% > 50% 
No. % No. % 
< 0.5 27 
3 11.1 24 88.9 
> 0.5 23 
19 82.6 4 17.4 
‘p’ 
0.0001 
Significant 
25.2
51.8
0
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RELATIONSHIP BETWEEN  
PRE/POST TVI & 
 % STENOSIS  
(Angiogram values) 
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Table  10:   Difference in the values of % Stenosis between Echo findings and Angiogram  
findings 
% Stenosis difference 
between Echo findings 
and Angiogram values 
 
 
Cases 
 
No. % 
< 10 % 30 60 
> 10% 20 40 
Total 50 100 
Range 
Mean 
S.D. 
-31% - (+ 59%) 
4.6% 
15.8% 
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Transesophageal Doppler echocardiographic determination of percent area stenosis  
According to the continuity equation, coronary flow volume at the prestenotic segment is 
equal to that at the stenotic segment in the absence of branches between the two segments. 
As flow volume is derived from the product of CSA with the TVI, thus,  
(1) 
The percent area stenosis (%CSA) is written as  
(2) 
Rearranging (1), (2) leads to  
(3) 
Coronary angiographic data  
The length of Left main coronary artery in angiogram varies between 4.5 to 22 mm with a 
mean of 11.5 and a standard deviation of 4.2.The diameter of left main coronary artery at 
ostial level ranges from 0.96 to 5.31 mm with a mean of 3.28 mm and standard deviation of 
0.84.  The diameter of left main coronary artery at shaft  level ranges from 1.4  to 5.03  mm 
with a mean of 3.04 mm and standard deviation of 0.89.  The diameter of left main coronary 
artery at  distal  level ranges from 1.11 to 4.37  mm with a mean of 2.54  mm and standard 
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deviation of 0.84. The calculated percent DS ranged from 20% to 90% (mean 43.2 and 
standard deviation of 15.7);  
Transesophageal Doppler echocardiographic data  
A localized increase in velocity appeared on Doppler color flow mapping as a localized area 
of aliased and disturbed signal in all 50 patients studied. In all patients, peak diastolic 
velocity and diastolic TVI at the prestenotic site were obtained by pulsed Doppler 
echocardiography; transstenotic diastolic peak velocity and TVI were obtained in all patients 
with the use of either pulsed Doppler echocardiography or high pulse repetition frequency 
Doppler or continuous wave Doppler echocardiography. The peak diastolic velocity at the 
stenotic region was 12 to 103 cm/ with a mean of 51.8 and standard deviation of 21.4 and 
was significantly higher than that measured at the prestenotic segment 5 to 53  cm/ with a 
mean of 25.2 and standard deviation of 11.4.. A good linear correlation was found between 
the catheterization-derived and TEDE-derived percent CSA stenosis (correlation coefficient 
of 0.6007)(significant>0.5)and length of left main coronary artery(correlation coefficient of 
0.7137(significant>0.5).A  good linear relation was also found between the catheterization-
derived percent DS and the simple prestenotic to stenotic TVI ratio, which was a good 
discriminator for distinguishing patients with ≥50% diameter reduction from those with 
<50% diameter reduction. All patients with ≥50% diameter reduction stenosis at 
catheterization had a TVI ratio ≤0.5 and only  four of the 50  patients with <50% diameter 
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reduction had a TVI ratio ≤0.5. Thus, a TVI ratio ≤0.5 predicted ≥50% diameter reduction 
with 90% sensitivity and 85% specificity. The diameter  of the coronary vessels did not 
correlate because the lateral resolution of the two-dimensional sector scan is too low to allow 
reliable measurements of dimensions of coronary arteries. The present study demonstrates 
that velocity measurements derived from TEDE can be used for quantitating stenosis of the 
LMCA . . 
Use of the continuity equation  
Three previously published reports 1., 2., 8. based on invasive Doppler measurements have 
proposed the application of the continuity equation to estimate the severity of coronary 
stenosis. However, the methods used in these previously published studies 1., 2., 8. remain 
invasive, requiring cardiac catheterization, and cannot be repeated without risk during serial 
follow-up studies. Furthermore, in their consecutive series of 52 patients undergoing 
percutaneous transluminal coronary angioplasty, Di Mario et al. (8) found that, although 
accurate for quantitation of lesion significance, use of the continuity equation employing 
intracoronary guide wire Doppler measurements is difficult and impractical for clinical 
application because high quality intrastenotic Doppler signals are obtained in only a minority 
of cases. 
In our study, we used a noninvasive approach—TEDE—which can be used more easily in a 
clinical setting. We found a good linear relation  between catheterization-derived and TEDE-
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derived percent CSA stenosis using the continuity equation. Despite this good linear relation, 
TEDE measurements significantly underestimated the actual percent CSA stenosis. This 
discrepancy between transesophageal Doppler measurements and the actual percent CSA 
may be explained by differences in the cross-sectional velocity profile that may occur 
between the prestenotic and stenotic segment sites. Fluid mechanics theory and previous 
published experimental studies suggest that cross-sectional velocity profile in a small 
conduit, like coronary arteries, is parabolic at a low Reynolds number, but flattens when 
velocities increase, like in a stenosis where flow becomes turbulent 20., 21., 22., 23., 24.. We 
have recently confirmed in a clinical study, based on computer analysis of digitally 
transferred transesophageal color coronary flow maps, that the cross-sectional velocity 
profile is parabolic in the normal proximal LAD, whereas it becomes flatter when velocities 
increase, like at the site of stenosis or after intravenous injection of dipyridamole (25). For 
clinical purposes, however, the simple TVI ratio may be used for predicting with good 
accuracy the percent DS, which is also a well recognized variable of stenosis severity. 
Clinical implications   
Our data suggest that TEDE allows quantitation of stenosis of the LMCA .This method offers 
the advantage of a noninvasive technique, which can be applied in many echocardiographic 
laboratories. Our TEDE method might also represent an adjunct to coronary angiography to 
evaluate mild to moderate stenosis. Conventional angiography with visual interpretation, as 
currently used in many catheterization laboratories, has significant limitations in the 
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assessment of coronary stenosis (26). In patients with severe coronary diameter reduction on 
the angiogram, there is usually no difficulty in ascertaining the functional severity of the 
lesion and in making clinical decisions. In contrast, in some patients with angiographically 
documented mild to moderate stenosis, it is sometimes difficult to evaluate the actual 
physiologic consequences of the obstruction. Also, contrast angiography, even when using 
quantitative angiography, is not necessarily suitable for evaluating the results of catheter-
based interventions owing to the eccentricity of the vascular lumen after angioplasty (27). As 
TEDE measurements using the continuity equation do not rely on any geometric assumption, 
it might help to confirm the functional severity of stenosis visualized by angiography, 
especially in cases of mild to moderate lesions and after catheter-based interventions. TEDE 
also provides a method for quantitating the severity of the stenosis without inserting any 
catheter or guide wire into the stenotic segment. In contrast, Doppler catheters or guide wires 
reduce the actual CSA of the stenosis and may disturb flow field, thus leading to some errors 
in measurements.  
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Two examples of LMCA stenosis patients with ECG,CAG,typical phasic coronary flow–
velocity signals recorded by TEDE in the prestenotic and transstenotic regions are illustrated 
below  
 
 
Patient underwent TMT with BRUCE PROTOCOL  achieved 95% of target heart rate 
and10.7 METS achieved. He had hypertensive response during exercise and developed 2mm 
ST depression in anterior chest leads V2-V6& ST elevation in aVR that persisted 2 minutes 
into recovery. 
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VEDAPPAN CAG 
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Trans Esophageal Echocardiogram 
 
Turbulence in LMCA at branching point 
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High velocity Jet in LMCA 
 
CASE2 
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GANDHI CAG 
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ECG OF GANDHI 
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THIRUVENKATAM CAG 
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CAG KALAIARASI 
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Quantification of LMCA Stenosis 
 100(I–pre-stenotic TVI/stenotic TVI)  
= 100 ( 1 – 30/40 ) 
= 100 ( 1 – 0.75) 
= 25% 
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LIMITATIONS OF THE STUDY   
Some limitations of this new technique must be addressed. In our study, we were able to 
obtain interpretable TEDE flow recordings at the site of both prestenotic and stenotic regions  
in only 50 of60 patients. 
The present study was designed to test the ability of TEDE, in comparison with digital 
quantitative angiographic data, for quantitating proximal LCA stenosis based on the 
continuity equation. However, the accuracy of this method in detecting the absence or 
presence of a significant stenosis in the proximal LCA in patients with various heart diseases 
on a large screening basis remains to be determined. 
Only patients with stenosis of the LMCA  were studied, and no attempt was made to explore 
circumflex and right coronary arteries. Owing to more severe angulation and tortuosity of 
these vessels, adequate Doppler signals, as well as a good alignment between the ultrasound 
beam and the axial flow direction, appear to be more difficult to obtain in the right coronary 
artery and the circumflex artery. However, computation of severity of stenosis of the LMCA  
provides clinically important information, because a major amount of myocardium is 
perfused by these vessels.The lateral resolution of the two-dimensional sector scan is too low 
to allow reliable measurements of dimensions of coronary arteries. 
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Continuity equation in coronary artery stenosis  
At any instant and at any site, the coronary flow rate (CFR) is equal to the product of spatial 
average velocity with the CSA:  
(4) 
In the prestenotic segment, assuming a parabolic velocity profile—that is, spatial average 
velocity is equal to half the peak axial velocity—CFR is written as  
(5) 
(6) 
In the stenotic segment, assuming a flat velocity profile—that is, spatial average velocity is 
equal to peak axial velocity—CFR is written as  
(7) 
(8) 
Rearranging (6), (8) demonstrates that the percent CSA reduction may be written as  
(9) 
Owing to the width of the pulsed Doppler sample volume and of the continuous wave 
Doppler beam compared with the small diameter of the coronary vessel, one can assume that 
peak velocity measurements derived from TEDE correspond to the actual peak axial velocity 
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within the vessel at any instant. In our study, TVIs were measured by planimetry of the peak 
velocity curve obtained by tracing the outer border of the Doppler spectral display on the 
recording, so that Equation 9 can be rewritten by substituting peak velocity by TVI:  
(10) 
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                                          Conclusion 
Transoesophageal Doppler assessment of coronary blood flow is a highly sensitive and 
specific non invasive method in the diagnostics of stenotic and occlusive atherosclerosis of 
the main coronary arteries. 
A modified continuity equation is haemodynamically correct and allows with application of  
Transoesophageal Doppler allows the accurate calculation of the coronary artery stenosis 
percentage. 
The peak diastolic velocity of coronary blood flow (equal to 1.4 m.s -1 in the LMCA,0.9 m.s-1 
in the LAD ,and 1.1 m.s-1 in the LCX) alongside the aliasing phenomenon is a Doppler 
criterion of haemodynamically significant stenosis. 
Break of colour mapping,absence of Doppler spectrum and registration of retrograde blood 
flow during late diastole are Doppler echocardiographic criteria for coronary coronary artery 
occlusion. 
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PROFORMA 
ASSESMENT OF LEFT MAIN CORONARY STENOSIS
        BY TRANSESOPHAGEAL ECHOCARDIOGRAPHY 
Name of the patient   :                                       Age :                    Sex: 
CD no :                                                              Address : 
Clinical diagnosis      : 
Brief history              : 
General examination : 
Build and nourishment 
Height 
Weight 
Waist circumference 
Hip measurement 
Waist hip ratio 
Pulse   : 
Blood pressure : 
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Cardiovascular system examination : 
Respiratory system examination : 
Abdomen  : 
CNS examination: 
Investigations : 
Urine    -     Albumin 
- Sugar 
-   Deposits 
Blood   -  Hb  
-         ESR 
Blood urea 
Blood sugar  - F 
                     - PP 
Serum creatinine 
Fasting lipid profile 
         Total – C           LDL – C            HDL – C 
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          TGL            VLDL 
ECG 
Echocardiogram : 
2 D and M mode echo :     
                     LVID (d)                      LVID (s) 
                     EF                        
                      
Doppler echo : 
         Mitral inflow  :  E 
                                   A 
                                  DT 
                                    E/A 
         
         TDI                     -  S’                  E’ 
                                        A’  E/E1 
3 D echo: 
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TRANSESOPHAGEAL ECHOCARDIOGRAPHY: 
LENGTH OF LEFT MAIN ARTERY: 
DIAMETER OF LMCA: 
         OSTIUM LEVEL: 
         SHAFT LEVEL: 
        DISTAL LEVEL: 
TVI BEFORE STENOSIS: 
TVI AFTER STENOSIS: 
PRESTENOTIC/POST STENOTIC RATIO: 
% OF STENOSIS OF LMCA: 
 
CORONARY ANGIOGRAPHIC DATA: 
LENGTH OF LEFT MAIN ARTERY: 
 
DIAMETER OF LMCA: 
         OSTIUM LEVEL: 
         SHAFT LEVEL: 
        DISTAL LEVEL: 
% OF STENOSIS OF LMCA: 
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S.NO NAME AGE SEX DIAGNOSIS DM ECG ST↑ ST↓ T↓ LVID(D) LVID(S) LVEF(T) LVEF(QLAB) MR RWMA E A DT S' E' A' E/E'
(CM) (CM)   (%)        (%) cm/s cm/s msec cm/s cm/s cm/s (ratio)
1 Vedappan 53 M Stable angina Nil ST↑avR avr v2‐ v6 v2 4.6 2.68 72 51 nil nil 63 61 126 7 8 6 8
2 Gandhi 50 M PWMI nil QV8V9 V8V9    _    _ 4.5 3.3 51 65 yes IWPW 62 47 134 7 6 6 10
3 Singadurai 50 M IWMI nil Qii,iii,avf ii,iii,avf    _ L1avl 3.7 2.6 55 49 Gri IW,IS 91 69 115 6 4 7 22
4 Leelavathy 42 F AWMI Nil QV1‐V6 V1‐V6 ii,iii,avf iii,avf 5.6 5.2 26 25 Gri AW,AS 79 51 154 4 4 6 20
5 Thangamuthu 50 M IWMI Nil ST↑iiiiiavf ii,iii,avf    _    _ 5.2 4.4 30 26 nil IW.IS 71 73 137 6 7 8 10
6 Thaniperavi 40 M IWMI Nil QsLiii,avf    _ V3V4 iii,avf 4.7 2.8 60 56 Gri Iw 65 72 124 7 6 6 11
7 Shikh hussain 52 M AWMI nil ST↑V2‐V4 V2‐V4 Li,avl V1‐V2 5.2 4.2 44 37 nil AW,AS 67 54 113 6 5 5 13
8 Marimuthu 48 M AWMI yes ST↑V1‐V6 V1‐V6 Li,avl L1avl 5.6 5.1 27 30 nil AW,AS 67 69 129 7 9 8 7
9 Ramakrishnan 55 M IWMI Nil Qii,iii,avf ii,iii,avf   _ L1avl 4.7 2.8 69 60 nil IW.IS 42 76 145 6 6 9 7
10 Annadurai 43 M AWMI yes QSV1‐V3 no V1‐V3 V1‐V2 4.1 3.3 40 45 nil AW,AS 49 58 174 5 5 9 10
11 Mohammedali 46 M AWMI Nil QSV1‐V3 no V1‐V3 V1‐V3 5.2 4.4 42 45 nil AW,AS 65 54 120 7 4 6 16
12 Ayyavu 58 M AWMI Nil QSV1‐V3 no V1‐V3 V1‐V3 4.5 3.3 50 46 nil AW,AS 50 58 174 5 5 9 10
13 Ramalingam 50 M Stable angina Nil Normal no nil nil 6 3.8 65 69 nil IW,IS 76 71 140 5 5 7 15
14 Thangaraj 70 M IWMI Nil QLiii,avf ii,iii,avf nil nil 4.8 3.4 41 45 nil IW,IS 75 73 117 6 8 7 9
15 Krishnamoorthy 65 M Stable angina Nil ST↓V4V6 no V4‐V6 V4‐V6 3.8 1.9 68 73 nil nil 62 53 130 7 4 6 15
16 Thiruvengadam 68 M AWMI Nil QV1‐V4 V1‐V4 nil nil 5.8 4.5 45 49 nil AW,AS 42 68 132 6 4 7 10
17 Balaguru 56 M AWMI Nil QV1‐V4 no V2‐V6 V2‐V6 7.1 6 32 38 nil AW,AS 65 45 133 4 5 5 13
18 Krishnamoorthy 58 M Stable angina Nil Normal no nil nil 4.9 3.5 54 48 nil nil 62 53 127 7 4 6 15
19 Elango 45 M IWMI yes QLiii,avf Lii,iii nil nil 4.3 3.6 37 35 Gri IW,IS 72 52 113 5 7 7 10
20 Padmavathy 66 F IWMI Nil QLiii,avf no Liii.avf V5,V6 4.5 2.5 73 56 Gri IW,IS 72 64 136 5 6 8 12
21 Sakthivel 50 M Stable angina Nil Normal no nil nil 5 3.9 60 48 Gri nil 75 73 133 6 8 7 9
22 Babu 48 M AWMI Nil ST↑V1‐V6 V1‐V4 nil nil 5.2 4.2 27 32 nil AW,AS 110 38 120 6 7 6 15
23 Shanmugam 61 M IWMI yes ST↑Liiiavf Lii,iii nil nil 5.1 4 38 43 Gri IW,IS 46 60 145 6 5 9 9
24 Murugesan 58 M IWMI Nil QLiii,avf    _ Liii.avf Liii.avf 5.4 4 42 36 nil IW,IS 43 76 143 6 6 9 7
25 Ramiah 60 M IWMI Nil QLiii,avf no Liii.avf Liii.avf 4.4 3.6 26 34 nil IW,IS 78 79 187 5 4 7 19
26 Ramakrishnan 55 M IWMI Nil QLiii,avf    _ Liii.avf Liii.avf 4.8 4.2 28 34 Gri IW,IS 36 46 56 5 5 5 7
27 Sethuraman 52 M IWMI Nil QLiii,avf Lii,iii nil nil 5.3 3.8 54 51 Gri IW,IS 64 67 132 5 6 8 10
28 Kalaiarasi 50 F Stable angina yes T↓V5V6   _ V5,V6 V5,V6 3.5 2 69 64 Gri nil 65 62 156 4 4 7 16
29 Radhakrishnan 53 M AWMI Nil QV3‐V6 no nil nil 5.4 3.6 61 48.8 Gri AW,AS 66 61 145 5 4 8 16
30 Jeyaraj 43 M IWMI yes QLiii,avf    _ Liii.avf Liii.avf 5.6 3.9 58 52 Gri IW,IS 82 70 122 6 5 7 16
31 Kathiresan 36 M AWMI yes QV1‐V4 no nil V1‐V3 4.9 3.3 50 45 Gri AW,AS 58 59 132 6 10 6 5
32 Mookiah 51 M Unstable ang Nil ST↓V4V6 no V4‐V6 V5,V6 4.6 2.9 54 50 nil nil 52 71 220 6 4 8 13
33 Govindaraj 48 M AWMI Nil QV1,V2 no V1‐V3 V1‐V3 4.9 3.3 42 38 Gri AW,AS 50 66 132 5 9 8 5
34 Abdulaziz 59 M Stable angina yes Normal no nil nil 5 3.4 59 60 nil nil 64 67 122 5 6 8 10
35 Jeyakodi 38 M Stable angina yes Normal no nil nil 5.7 4.1 50 54 nil Iw 68 69 132 5 5 11 13
36 Vembu 52 M AWMI yes ST↑V1‐V6 V1‐V4 Liii.avf Liii.avf 5.9 5 31 36 Gri AWAS 52 62 132 9 5 6 10
37 Natarajan 62 M IWMI Nil QLiii,avf no Liii.avf Liii.avf 5.4 4.9 17 25 Gri AWAS 79 27 96 4 2 5 40
38 Sunderrajan 54 M Stable angina Nil ST↓V4V6 no V4‐V6 V4‐V6 4.8 3.3 48 39 nil nil 51 70 238 5 3 8 17
39 Ravi 40 M Unstable ang Nil ST↓V4V6 no V4‐V6 V4‐V6 5.2 3.2 52 40 nil HYAW 50 60 198 7 8 8 6
40 Sivasubramanian 58 M Stable angina Nil ST↓Liavl no Liavl Liavl 5.4 3.2 60 62 nil nil 36 62 146 6 5 9 7
41 Navaneethammal 66 F Unstable ang yes ST↓V4V6 no V4‐V6 V4‐V6 4.3 3.7 27 30 nil IW,IS 92 61 126 7 6 5 16
42 Mookan 60 M Unstable ang Nil ST↓V4V6 no V4‐V6 V4‐V6 5.2 3.8 44 39 Gri AWAS 66 61 162 5 4 8 16
43 Indhurani 56 F Unstable ang Nil ST↓V4V6 no V4‐V6 V4‐V6 5 3.9 39 46 Gri AWAS 38 47 65 5 5 5 7
44 Muthiah 65 M Unstable ang yes ST↓V4V6 no V4‐V6 V4‐V6 6 5.1 33 46 Gri AWAS 58 59 137 6 10 6 5
45 Mohanganapathy 56 M AWMI yes ST↑V1‐V6 V1‐V4 nil nil 5 3.6 53 43 nil AW,AS 87 42 148 6 7 8 12
46 Jebamalai 59 M AWMI Nil ST↑V1‐V6 V1‐V4 nil V1‐V3 6 5 35 43 Griii AWAS 68 73 129 7 8 8 8
47 Krishnasamy 48 M AWMI yes ST↑V1‐V6 V1‐V4 nil nil 6 5 35 39 nil AWAS 78 71 146 6 8 8 9
48 Ramamoorthy 59 M AWMI yes QV1‐V6 no V1‐V3 V1‐V3 5.3 4.3 48 26 Gri AWAS 60 50 227 5 5 5.1 12
49 Marri 52 M Stable angina Nil Normal no nil avl 4.3 2.98 60 45 nil nil 82 66 221` 7 8 7 8
50 Syed 62 M OldIWMI Nil QLiii,avf    _ Liii.avf Liii.avf 5.4 4.6 42 47 nil IW,IS 58 56 111 7 6 6 9


S.NO NAME                CORONARY ANGIOGRAM
LMCA(L)cm DIAMETER(O)cm SHAFT cm BIFURcm TVI(BEF) TVI(AFTE) %STENOS) pre/potvi LMCA(L)cm DIA(O)cm DIA(S)cm DIA(B)cm %STENOS
1 Vedappan 7.46 3.2 3.8 3.1 17 23 27 0.73 8.39 3.67 4.22 3.96 20
2 Gandhi 8.12 2.6 2.2 2 25 53 53 0.47 9.4 4.07 4.53 3.44 50
3 Singadurai 18.8 4.2 3.9 1.7 28 43 35 0.65 21.85 4.4 4.17 3.05 30
4 Leelavathy 9 2.6 1.9 4.2 22 31 30 0.7 7.64 2.15 1.87 2.04 20
5 Thangamuthu 14 3 2.1 3 38 91 59 0.41 18.48 3.73 2.91 4.25 50
6 Thaniperavi 6.8 4.3 4.3 3.9 42 83 50 0.5 7.96 4.05 4.21 3.29 50
7 Shikh hussain 6.2 5.2 5 4.7 43 56 24 0.76 16 5.31 5.03 3.59 30
8 Marimuthu 8.1 4.2 5.2 4.1 31 42 27 0.73 7.37 2.78 3.96 4.24 30
9 Ramakrishnan 7.5 2.9 3 2.6 29 38 24 0.76 7.35 3 2.99 2.27 20
10 Annadurai 10 5 4.2 2.5 28 64 57 0.43 11 3.5 3.14 2.27 50
11 Mohammedali 10.1 5 5 3.4 42 54 30 0.71 10.5 2.93 3.29 2.19 30
12 Ayyavu 5.5 2 3.7 2.9 47 67 30 0.73 17 4.5 2.9 3.7 50
13 Ramalingam 14 4.4 4.1 3 23 63 64 0.36 15.7 3.88 3.88 2.3 50
14 Thangaraj 7 2 2.2 2.5 17 29 42 0.58 8.48 3.28 2.61 3.04 30
15 Krishnamoorthy 9 4 2.8 3 23 49 54 0.46 12 4.07 2.32 3.77 50
16 Thiruvengadam 15 2.5 3.9 3 27 39 31 0.69 16 2.82 3.32 1.97 30
17 Balaguru 3.9 4.1 2.5 2.6 29 72 60 0.4 6.97 3.96 3.68 2.23 60
18 Krishnamoorthy 11 4.4 2.7 2.3 30 70 58 0.42 12.62 4.33 2.44 3.55 50
19 Elango 7.4 2.7 3.7 3 49 60 19 0.81 4.55 2.48 2.04 1.29 50
20 Padmavathy 11.2 3.9 3.2 2.8 30 66 56 0.44 11.18 4.07 4.07 2.94 50
21 Sakthivel 12.1 5.8 4.9 2.2 16 83 81 0.19 9.37 2.9 3.16 1.9 75
22 Babu 10.4 3 4 2.2 27 68 61 0.39 11.1 2.84 2.87 1.45 60
23 Shanmugam 13.2 5 4.2 3.9 18 51 65 0.35 14 4.65 4.98 3.12 50
24 Murugesan 6.2 3.2 2.1 3.4 29 66 57 0.43 4.82 2.76 1.53 2.47 50
25 Ramiah 8.4 5.5 4.1 3 24 55 57 0.43 7.99 4.3 2.13 2.31 50
26 Ramakrishnan 10.1 6.9 5.2 6.3 15 19 22 0.78 9.48 3.9 3.41 3.95 20
27 Sethuraman 14.1 5.7 2.9 2.4 32 76 58 0.42 16.47 3.78 3.82 2.4 70
28 Kalaiarasi 8.4 4.6 4.3 3.2 30.8 40.2 25 0.75 7.7 4.01 4.02 2.29 30
29 Radhakrishnan 10 2.5 2.1 2.2 16 18 12 0.88 11.13 3.13 2.75 2.91 20
30 Jeyaraj 7 2.5 3.6 2.3 21.6 47 55 0.45 5.73 2.4 2.4 1.85 30
31 Kathiresan 12 3 4 3.6 25 56 56 0.44 14.77 2.51 2.3 3 50
32 Mookiah 13 3 2.9 2.2 32 68 53 0.47 14.24 3 2.12 1.52 50
33 Govindaraj 14 5.7 5 3.3 11 19 43 0.57 13.63 3.09 3.38 2.48 30
34 Abdulaziz 13 2.8 4.3 3.8 29.5 70.5 59 0.41 14.35 3.92 4.14 2.2 75
35 Jeyakodi 18.7 4 3.8 3 53 103 49 0.51 21 3.08 2.8 1.54 50
36 Vembu 10 4.1 3.2 3.4 20 45 56 0.44 9.59 3.03 1.77 1.77 50
37 Natarajan 7 3 2.8 2.1 10 31.7 69 0.31 6.67 3.6 3.16 2.25 50
38 Sunderrajan 9 4.7 4.9 4 17.5 50.5 60 0.34 13.51 3.59 3.81 1.96 50
39 Ravi 8 3.4 2.9 2.6 14.3 21 32 0.68 8.87 2.73 2.77 1.83 20
40 Sivasubramanian 11 4 3.9 3 11 36 70 0.3 7.9 3.39 2.57 1.68 50
                                       TRANSESOPHAGEAL ECHOCARDIOGRAPH
41 Navaneethammal 10 2.4 3.2 3 7 12 42 0.58 8.46 1.92 2.32 2.56 40
42 Mookan 7.8 3 2.1 2 5 46 89 0.11 11.38 2.47 2.21 1.86 30
43 Indhurani 14 3 1.7 1.9 26 30 14 0.86 22 2.77 1.48 2.46 40
44 Muthiah 11.6 2.8 3.6 3 23 51 55 0.45 11.75 0.96 2.45 2.3 50
45 Mohanganapathy 8.6 4 3.7 2.3 15.6 95.4 80 0.16 12.84 2.31 3.09 1.89 50
46 Jebamalai 7.5 3 2.3 3.7 12.3 15.2 20 0.8 14.98 4.06 3.27 4.39 30
47 Krishnasamy 8 5 4.5 4 7 61 80 0.11 9.21 2.99 3.32 2.31 30
48 Ramamoorthy 9 3.8 2.9 3.8 46.2 60.6 24 0.7 9.87 2.06 1.4 2.38 30
49 Marri 6 3.8 3.8 1.3 28.7 57.3 49 0.5 9.6 2.1 2.37 1.49 40
50 Syed 9.1 3.8 2.9 2.2 15 43.2 66 0.34 12.39 2.88 2.81 1.11 90
